Coronary Heart Disease in Patients With DiabetesPart II: Recent Advances in Coronary Revascularization
Colin Berry, MD, PhD2,
Jean-Claude Tardif, MD, FACC1 and
Martial G. Bourassa, MD, FACC*
Department of Medicine, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Cumulative Survival Rates After PTCA or CABG in Diabetic and Nondiabetic Patients
Cumulative un-adjusted survival in 1,041 patients (8% with treated diabetes mellitus [DM]) who underwent coronary artery bypass grafting (CABG) between 1970 and 1985 and 702 (11% with treated DM) who underwent first percutaneous transluminal coronary angioplasty (PTCA) between 1980 and 1985. Analyses of patients after 10 to 20 years follow-up revealed survival rates in surgically treated patients to be lower than PTCA-treated patients. Reproduced from van Domburg et al. (15) with permission.
|
|
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Glycemic Control and Outcomes 1 Year After PCI
(A) Relationships between glycemic control and target vessel revascularization (TVR) at 12 months after elective percutaneous coronary intervention (PCI). (B) Relationships between TVR in diabetic patients treated with or without insulin and in patients without diabetes undergoing elective PCI. Reproduced from Corpus et al. (64) with permission.
|
|
|
